Evidence map›Paper›PMID 31300958›Full record

ReviewBiological trace element research2019

Selenoproteins of the Human Prostate: Unusual Properties and Role in Cancer Etiology.

Alan M Diamond

Open access · greenAbstract readReview
In one paragraph

Review in Biological trace element research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. "Alphabet" Selenoproteins: Implications in Pathology.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. NovelAntioxidants (Basel, Switzerland) · 2021
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Alan M DiamondDepartment of Pathology, College of Medicine, University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, IL, 60612, USA. adiamond@uic.edu.ORCID http://orcid.org/0000-0001-6032-1293
Illinois College · US

Funding

Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6M
The role of MnSOD allelic variations in prostate cancer etiology and outcomeR01CA193497 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DIAMOND, ALAN, PRINS, GAIL S · 2015 to 2017
$1.2M
Anti-oxidant enzymes and prostate cancerR21CA182103 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DIAMOND, ALAN · 2014 to 2015
$473k
NCI NIH HHS R01 CA193497NCI NIH HHS R21 CA182103NIEHS NIH HHS P30 ES027792NIH HHS R01CA193497NIH HHS R21CA182103
6 · The paper itself

Abstract

The prostate is an important organ for the maintenance of sperm health with prostate cancer being a common disease for which there is a critical need to distinguish indolent from aggressive disease. Several selenium-containing proteins have been implicated in prostate cancer risk or outcome due to either enzyme function, the reduced levels of these proteins being associated with cancer recurrence after prostatectomy or their corresponding genes containing single-nucleotide polymorphisms associated with increased risk. Moreover, experimental data obtained from the manipulation of either cultured cells or animal models have indicated that some of these proteins are contributing mechanistically to prostate cancer incidence or progression. Among these are selenocysteine-containing proteins selenoprotein P (SELENOP), glutathione peroxidase (GPX1), and selenoprotein 15 (SELENOF); and the selenium-associated protein selenium-binding protein 1 (SBP1). Genotyping of some of the genes for these proteins has identified functional single-nucleotide polymorphisms that are associated with prostate cancer risk and the direct quantification of these proteins in human prostate tissues has not only revealed associations to clinical outcomes but have also identified unique properties that are different from what is observed in other tissue types. The location of GPX1 in the nucleus and SELENOF in the plasma membrane of prostate epithelial cells indicates that these proteins may have functions in normal prostate tissue that are distinct from that of the other tissue types.

Indexed as

Cell MembraneEpithelial CellsNeoplasm ProteinsProstateProstatic NeoplasmsSelenoproteinsHumansMaleNeoplasm ProteinsSelenoproteinsGlutathione peroxidaseSeleniumSelenium-binding protein 1Selenoprotein FSelenoproteins

Identifiers

PMID31300958
PMCPMC6801063
OpenAlexW2956329047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.